Systemic lupus erythematosus and autoimmune features in chronic hospitalized patients with schizophrenia

This publication has 32 references indexed in Scilit:

• Automated evaluation of autoantibodies on human epithelial-2 cells as an approach to standardize cell-based immunofluorescence tests
  Arthritis Research & Therapy, 2010
• Common variants on chromosome 6p22.1 are associated with schizophrenia
  Nature, 2009
• Psychosis due to systemic lupus erythematosus: characteristics and long-term outcome of this rare manifestation of the disease
  Rheumatology, 2008
• The Complement System in Schizophrenia
  Drug News & Perspectives, 2008
• MBL and L-ficolin components of the complement activation lectin pathway in schizophrenia
  Molecular Immunology, 2007
• Epidemiology of Schizophrenia: Review of Findings and Myths
  Psychiatric Clinics of North America, 2007
• Controlled clinical trial of IV cyclophosphamide versus IV methylprednisolone in severe neurological manifestations in systemic lupus erythematosus
  Annals of the Rheumatic Diseases, 2005
• Remission in Schizophrenia: Proposed Criteria and Rationale for Consensus
  American Journal of Psychiatry, 2005
• Updating the American college of rheumatology revised criteria for the classification of systemic lupus erythematosus
  Arthritis & Rheumatism, 1997
• The UKU side effect rating scale: A new comprehensive rating scale for psychotropic drugs and a cross‐sectional study of side effects in neuroleptic‐treated patients
  Acta Psychiatrica Scandinavica, 1987